Clinical Trial Update: Breast-Sparing Proton Therapy for Hodgkin's Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial of breast-sparing proton therapy for Hodgkin lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Indiana University | Conditions: Hodgkins Disease | EARLY_Phase 1 | Status: TERMINATED